Results and Implications From the Open-Label Arm of the TRuE-V Long-Term Extension Phase 3 Study

home / between-the-lines / results-and-implications-from-the-open-label-arm-of-the-true-v-long-term-extension-phase-3-study

Gary Owens, MD, and David Rosmarin, MD, highlight key takeaways in vitiligo treatment as produced by the TRuE-V studies.

Drs. Owens and Rosmarin discuss an overview of the TRuE-V studies and unmet needs in vitiligo.

Watch

The key safety and efficacy data of the TRuE-V studies are discussed.

Watch

The study design for the TRuE-V long-term extension study is discussed.

Watch

Dr. Rosmarin discusses the efficacy data from the TRuE-V long-term extension study.

Watch

Key adverse events from the TRuE-V studies are highlighted.

Watch

The limitations from the TRuE-V studies are analyzed.

Watch

Drs. Owens and Rosmarin discuss payer and provider perspectives from the TRuE-V studies.

Watch

Contact Info

2 Commerce Drive
Cranbury, NJ 08512